MGP
ONC

M&G plc’s BeOne Medicines Ltd ONC Stock Holding History

M&G plc’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41M Buy
138,163
+8,372
+6% +$2.71M 0.21% 89
2025
Q4 		$39.5M Buy
129,791
+9,070
+8% +$2.97M 0.2% 95
2025
Q3 		$41.2M Sell
120,721
-49,481
-29% -$15M 0.22% 94
2025
Q2 		$41.2M Sell
170,202
-15,829
-9% -$3.88M 0.23% 96
2025
Q1 		$50.6M Sell
186,031
-7,132
-4% -$1.67M 0.24% 77
2024
Q4 		$35.7M Buy
193,163
+20,088
+12% +$4.1M 0.22% 99
2024
Q3 		$38.9M Sell
173,075
-6,704
-4% -$1.21M 0.14% 106
2024
Q2 		$25.7M Sell
179,779
-10,277
-5% -$1.58M 0.1% 123
2024
Q1 		$29.6M Buy
+190,056
New +$30.6M 0.11% 105

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return